selected scholarly activity
-
chapters
- Stroke. 2133-2141. 2018
- Stroke. 2133-2141. 2017
- Cryptogenic Stroke. 707-715. 2016
-
conferences
- Early Metformin in Gestational Diabetes. Journal of the American Medical Association (JAMA). 1547-1547. 2023
- 183-LB: A Randomized Placebo-Controlled Trial of the Effectiveness of Early Metformin in Addition to Usual Care in the Reduction of Gestational Diabetes Mellitus Effects (EMERGE). Diabetes. 2023
- Adaptive design methods in dialysis clinical trials – a systematic review. Nephrology Dialysis Transplantation. 469-469. 2021
- 123 Empowering Patients after Stroke: Development of a Stroke Information Booklet. Age and Ageing. iii17-iii65. 2019
- 239 Setting Bones and Getting Home: The Impact of a New Orthogeriatric Service. Age and Ageing. iii17-iii65. 2019
- 258 FLEXIT: Geriatric Muscle on the Orthopedic Ward. Age and Ageing. iii17-iii65. 2019
- 25 Managing cardiovascular disease (CVD) risk factors in stroke and tia patients as part of an integrated community based preventive cardiology programme. Heart. A19-A20. 2018
- ASSOCIATION BETWEEN KEY PERFORMANCE INDICATORS AND PATIENT OUTCOMES IN LOWAND MIDDLE-INCOME COUNTRIES IN THE INTERSTROKE STUDY. International Journal of Stroke. 238-238. 2018
- MOBILITY-RELATED CARE AFTER STROKE IN THE RWANDAN AND SOUTH AFRICAN CONTEXT: IDENTIFYING OPPORTUNITIES FOR IMPROVEMENT THROUGH THE ORGANIZED STROKE CARE ACROSS INCOME LEVELS (OSCAIL) STUDY. International Journal of Stroke. 114-114. 2018
- 117An Audit of Oral Hygiene in an Acute Stroke Unit; Paving a Path for Improved Dental Care. Age and Ageing. iii13-iii59. 2017
- An Audit of Oral Hygiene in an Acute Stroke Unit; paving a path for improved dental care. Irish Journal of Medical Science. S238-S239. 2017
- MEASURING THE PATTERN AND IMPACT OF INTERNATIONAL PRACTICE VARIATIONS IN THE MANAGEMENT OF ACUTE STROKE PATIENTS IN THE INTERSTROKE STUDY: ACCESS TO STROKE UNIT CARE. International Journal of Stroke. 264-264. 2016
- APPLYING TOYOTA LEAN MANUFACTURING PRINCIPLES TO STROKE CARE IN AN IRISH UNIVERSITY HOSPITAL. Age and Ageing. 20-20. 2016
- SY 09-2 SALT INTAKE. Journal of Hypertension. e184-e184. 2016
- Most patients in stroke rehab are not eligible for independent walking interventions: Lessons from the IMPACT walking study. International Journal of Stroke. 7-7. 2015
- Sensitivity and Reliability of MRI SWI Compared With GRE Sequences for Detecting Microbleeds in a Community Population. Stroke. 2015
- What About the Other 12 Hours? Development and Pilot Testing of a Novel Program to Increase Walking-Related Practice During Stroke Rehabilitation. Stroke. E286-E286. 2014
- Transient Ischaemic Attack. International Journal of Stroke. 28-28. 2014
- Leflunomide Use Is Not Associated with an Increased Risk of Lung Disease in Rheumatoid Arthritis: A Meta-Analysis of Randomised Controlled Trials. Arthritis & Rheumatology. S205-S205. 2014
- Stroke unit services across 32 countries: A survey of participants in the interstroke study. International Journal of Stroke. 297-298. 2014
- Attitudes to Importance of Outcome Measures in Cardiovascular Prevention Trials. Irish Journal of Medical Science. S329-S329. 2014
- Audit of Stroke Management at a University Teaching Hospital. Irish Journal of Medical Science. S329-S330. 2014
- Can We Utilise Hospital Readmission Rates as a Key Performance Indicator?. Irish Journal of Medical Science. S368-S368. 2014
- Stroke unit services across 30 countries; a survey of participants in the INTERSTROKE study. Cerebrovascular Diseases. 468-468. 2014
- Frequent Atrial Premature Beats Predict Occult Paroxysmal Atrial Fibrillation in Patients with Cryptogenic Stroke: Results From the Embrace Multicentre Trial. Stroke. E185-E185. 2013
- Resting heart rate and decline in cognitive function: observations from the ONTARGET/TRANSCEND studies. European Heart Journal. 499-500. 2013
- Methotrexate and interstitial lung disease in rheumatoid arthritis-a systematic literature review and meta-analysis. Irish Journal of Medical Science. S94-S94. 2013
- OSTEOPOROSIS AND VERTEBRAL FRACTURES ARE IMPORTANT DETERMINANTS OF CARDIOVASCULAR DISEASE IN RHEUMATOID ARTHRITIS. Osteoporosis International. S146-S146. 2013
- VERTEBRAL FRACTURE ASSESSMENT-DETECTED ABDOMINAL AORTIC CALCIFICATION AND CARDIOVASCULAR DISEASE IN RHEUMATOID ARTHRITIS. Osteoporosis International. S145-S146. 2013
- Global availability of stroke unit care; a survey of participants in the INTERSTROKE study. Cerebrovascular Diseases. 474-474. 2013
- Implementing telemedicine in acute stroke: staff perspective. International Journal of Stroke. 8-8. 2012
- Methotrexate and Interstitial Lung Disease in Rheumatoid Arthritis - A Systematic Literature Review and Meta-Analysis. Arthritis and Rheumatism. S918-S918. 2012
- Osteoporosis and Vertebral Fractures Are Important Determinants of Cardiovascular Disease in Rheumatoid Arthritis.. Arthritis and Rheumatism. S359-S359. 2012
- Vascular Calcification On Hand and Feet X-Rays, VFA Imaging of the Spine, and Cardiovascular Disease in Rheumatoid Arthritis.. Arthritis and Rheumatism. S536-S537. 2012
- Vertebral Fracture Assessment-Detected Abdominal Aortic Calcification Enhances Cardiovascular Disease Risk Stratification of Rheumatoid Arthritis Patients.. Arthritis and Rheumatism. S721-S721. 2012
- Audit of Acute Stroke Care: From the Emergency Department to the Acute Stroke Unit. Irish Journal of Medical Science. S277-S277. 2012
- Closing the Audit Loop: Stroke Care in a University Hospital Three Years On. Irish Journal of Medical Science. S260-S260. 2012
- Vascular Risk Factors and Functional Impairment in Community Dwelling Older Adults in the West of Ireland. Irish Journal of Medical Science. S259-S260. 2012
- Association between therapeutic INR, survival and reduced disability in atrial fibrillation and stroke-systematic review and meta-analysis. Irish Journal of Medical Science. S328-S329. 2011
- AVERROES: Apixaban Versus Acetylsalicylic Acid (ASA) to Prevent Strokes. Stroke. E81-E81. 2011
- Effect of Apixaban on Covert Stroke and Cognitive Function: AVERROES MRI-Brain Assessment Trial. Stroke. E162-E162. 2011
- The PLAN Score: A Simple Prediction Rule for Death and Severe Disability Following Acute Ischemic Stroke. Stroke. E79-E79. 2011
- Stroke mortaltiy: derivation and validation of a clinical risk score. Stroke. E485-E485. 2010
- Diabetes Mellitus Modifies the Association Between Particulate Air Pollution and Acute Ischemic Stroke: Results from the Registry of the Canadian Stroke Network. Epidemiology. S65-S65. 2009
- Temperature and the Risk of Acute Ischemic Stroke: Results from the Registry of the Canadian Stroke Network. Epidemiology. S64-S64. 2009
- Etiology and Clinical Outcome of Stroke in Patients under 45 years.. Stroke. E191-E191. 2009
- Escalating levels of access to in-hospital care and stroke mortality. Neurology. A203-A203. 2008
- Comparing variables associated with 7-day, 30-day and 1-year stroke mortality indicators. Stroke. 698-698. 2008
- Organized care and impact on stroke outcome. Stroke. 702-702. 2008
- Stroke mortality: Does hospital volume matter?. Neurology. A224-A225. 2007
- Association between time-to-presentation and clinical outcome in patients with subarachnoid hemorrhage. Stroke. 542-542. 2007
- Gastrointestinal bleeding after acute ischemic stroke: Incidence, risk factors, and clinical outcomes. Stroke. 513-513. 2007
- Noninvasive cardiac monitoring for detecting paroxysmal atrial fibrillation or flutter following acute ischemic stroke: A systematic review. Stroke. 522-522. 2007
- Stroke mortality: What do the 7-day, 30-day, and 1-year indicators measure?. Stroke. 573-573. 2007
- Stroke: High volumes, low in-hospital mortality. Stroke. 479-479. 2007
- Evaluation of a VENOus-Return assist device (Venowave (TM)) to treat severe post-thrombotic syndrome (VENOPTS): A randomized controlled trial.. Blood. 263A-263A. 2006
- Influence of preadmission antithrombotic therapy on stroke severity in patients with atrial fibrillation. Stroke. 662-663. 2006
- Relative importance of individual vascular risk factors for competing risk of ischemic stroke and myocardial infarction. Stroke. 718-718. 2006
- I. Grades of recommendations and the levels of evidence. Journal des Maladies Vasculaires. 2005
- Predictors of response to low-molecular-weight heparin following ischemic stroke in patients with atrial fibrillation: A subgroup analysis of HAEST. Stroke. 451-451. 2005
- Thyroid replacement therapy is a risk factor for atrial fibrillation in stroke patients. Stroke. 503-503. 2005
- Effects of a novel venous-return assist device ("venowave") on lower limb venous flow in patients with post-thrombotic syndrome. Blood. 117B-117B. 2002
- Reduction of out-of-hospital symptomatic venous thromboembolism by extended thromboprophylaxis with low molecular weight heparin following elective hip arthroplasty. A systematic review.. Blood. 703A-703A. 2002
-
journal articles
- Rivaroxaban, in combination with low-dose aspirin, is associated with a reduction in proinflammatory and prothrombotic circulating vesicle signatures in patients with cardiovascular disease.. Journal of Thrombosis and Haemostasis. S1538-7836(24)00579-8. 2024
- Improving analysis of cognitive outcomes in cardiovascular trials using different statistical approaches.. Trials. 25:644. 2024
- Behavioral Sleep Interventions and Cardiovascular Risk Factors. Journal of Cardiovascular Nursing. 39:E158-E171. 2024
- Multimodal Artificial Intelligence in Medicine.. Kidney360. 2024
- Activity limitations, use of assistive devices, and mortality and clinical events in 25 high-income, middle-income, and low-income countries: an analysis of the PURE study. The Lancet. 404:554-569. 2024
- Blood pressure variability in acute stroke: Risk factors and association with functional outcomes at 1 month. European Journal of Neurology. 31:e16314. 2024
- Markers of periodontal disease and risk of stroke: INTERSTROKE case-control study. Journal of Stroke and Cerebrovascular Diseases. 33:107803-107803. 2024
- Long-term colchicine for the prevention of vascular recurrent events in non-cardioembolic stroke (CONVINCE): a randomised controlled trial. The Lancet. 404:125-133. 2024
-
Pre‐morbid sleep disturbance and its association with stroke severity: results from the international
INTERSTROKE study. European Journal of Neurology. 31:e16193. 2024 - Early Metformin in Gestational Diabetes. Obstetrical and Gynecological Survey. 79:193-195. 2024
- Tobacco use and risk of acute stroke in 32 countries in the INTERSTROKE study: a case–control study. EClinicalMedicine. 70:102515-102515. 2024
- Cognitive performance following stroke, transient ischaemic attack, myocardial infarction, and hospitalisation: an individual participant data meta-analysis of six randomised controlled trials. The Lancet Healthy Longevity. 4:e665-e674. 2023
- Comparing functional and quality of life outcomes in transcatheter aortic valve implantation and surgical aortic valve replacement for aortic stenosis: a systematic review and meta-analysis. BMC Cardiovascular Disorders. 23:519. 2023
- Antiplatelet therapy and incident cognitive impairment or dementia—a systematic review and meta-analysis of randomised clinical trials. Age and Ageing. 52:afad197. 2023
- Characteristics, clinical practice patterns, and outcomes of strokes in India: INSPIRE—A multicentre prospective study. International Journal of Stroke. 18:965-975. 2023
- Global mean potassium intake: a systematic review and Bayesian meta-analysis. European Journal of Nutrition. 62:2027-2037. 2023
- Diet, cardiovascular disease, and mortality in 80 countries. European Heart Journal. 44:2560-2579. 2023
- Response to letter by Campbell et al. regarding the results of the COSTICK trial. EClinicalMedicine. 61:102054-102054. 2023
- Population attributable fraction of hypertension for dementia: global, regional, and national estimates for 186 countries. EClinicalMedicine. 60:102012-102012. 2023
- Weight loss is proportional to increases in fasting serum beta-hydroxybutyrate concentrations in adults with severe obesity undergoing a meal replacement programme. Journal of Nutrition & Intermediary Metabolism. 32:200192-200192. 2023
- Sleep Patterns and the Risk of Acute Stroke. Neurology. 100:e2191-e2203. 2023
- Global Variations in Heart Failure Etiology, Management, and Outcomes. Journal of the American Medical Association (JAMA). 329:1650-1650. 2023
- Depressive Symptoms and Risk of Acute Stroke. Neurology. 100:e1787-e1798. 2023
- A comparative analysis of the Irish post-graduate geriatric medicine training scheme with the European post-graduate curriculum in geriatric medicine. European Geriatric Medicine. 14:397-400. 2023
- Randomised controlled trials of antihypertensive therapy: does exclusion of orthostatic hypotension alter treatment effect? A systematic review and meta-analysis. Age and Ageing. 52:afad044. 2023
- Dietary counselling to reduce moderate sodium intake: effects on cardiovascular and renal biomarkers: primary findings of the COSIP and STICK phase II feasibility randomised controlled trials. EClinicalMedicine. 57:101856-101856. 2023
- Effects of a Polypill, Aspirin, and the Combination of Both on Cognitive and Functional Outcomes. JAMA Neurology. 80:251-251. 2023
- Alcohol Intake as a Risk Factor for Acute Stroke. Neurology. 100:e142-e153. 2023
- Acute stress symptoms 1–2 weeks after stroke predict the subsequent development of post-traumatic stress symptoms: A prospective cohort study. PLoS ONE. 18:e0286220-e0286220. 2023
- Risk Factors for Stroke in the Young (18–45 Years): A Case-Control Analysis of INTERSTROKE Data from 32 Countries. Neuroepidemiology. 57:275-283. 2023
- World-wide variations in tests of cognition and activities of daily living in participants of six international randomized controlled trials. Cerebral Circulation - Cognition and Behavior. 5:100176-100176. 2023
- Long-Term Treatment with the Combination of Rivaroxaban and Aspirin in Patients with Chronic Coronary or Peripheral Artery Disease: Outcomes During the Open Label Extension of the COMPASS trial. European Heart Journal (EHJ) - Cardiovascular Pharmacotherapy. 8:786-795. 2022
- Are clinical trials randomising households to lifestyle interventions to delay cognitive decline feasible? A pilot study to determine the beliefs, preferences, and deterrents for households impacted by dementia based on semi-structured interviews. BMC Geriatrics. 22:322. 2022
- Association of Psychosocial Stress With Risk of Acute Stroke. JAMA network open. 5:e2244836-e2244836. 2022
- Publisher Correction: Stroke genetics informs drug discovery and risk prediction across ancestries. Nature. 612:E7-E7. 2022
- Higher Waist Hip Ratio Genetic Risk Score Is Associated with Reduced Weight Loss in Patients with Severe Obesity Completing a Meal Replacement Programme. Journal of Personalized Medicine. 12:1881-1881. 2022
- Stroke genetics informs drug discovery and risk prediction across ancestries. Nature. 611:115-123. 2022
- INTERBLEED: Design of an International Study of Risk Factors for Gastrointestinal Bleeding and Cardiovascular Events After Gastrointestinal Bleeding. CJC OPEN. 4:996-1005. 2022
- Contribution of Common Genetic Variants to Risk of Early-Onset Ischemic Stroke. Neurology. 99:e1738-e1754. 2022
- Effect of a Run‐In Period on Estimated Treatment Effects in Cardiovascular Randomized Clinical Trials: A Meta‐Analytic Review. Journal of the American Heart Association. 11:e023061. 2022
- A randomised placebo-controlled trial of the effectiveness of early metformin in addition to usual care in the reduction of gestational diabetes mellitus effects (EMERGE): study protocol. Trials. 23:795. 2022
- Settling the controversy of salt substitutes and stroke: sodium reduction or potassium increase?. European Heart Journal. 43:3365-3367. 2022
- Does prior use of antiplatelet therapy modify the effect of dual antiplatelet therapy in transient ischaemic attack/minor ischaemic stroke: A systematic review and meta‐analysis. European Journal of Neurology. 29:2864-2868. 2022
- Endovascular thrombectomy and intravenous alteplase in patients with acute ischemic stroke due to large vessel occlusion: A clinical practice guideline. Journal of Evidence-Based Medicine. 15:263-271. 2022
- Rivaroxaban versus aspirin for prevention of covert brain infarcts in patients with embolic stroke of undetermined source: NAVIGATE ESUS MRI substudy. International Journal of Stroke. 17:799-805. 2022
- Association of Lipids, Lipoproteins, and Apolipoproteins with Stroke Subtypes in an International Case Control Study (INTERSTROKE). Journal of Stroke. 24:224-235. 2022
- Rivaroxaban versus aspirin on functional and cognitive outcomes after embolic stroke of undetermined source: NAVIGATE ESUS trial. Journal of Stroke and Cerebrovascular Diseases. 31:106404-106404. 2022
- Functional Abilities of an International Post-Stroke Population: Standard Assessment of Global Everyday Activities (SAGEA) Scale. Journal of Stroke and Cerebrovascular Diseases. 31:106329-106329. 2022
- Mitochondrial DNA Copy Number as a Marker and Mediator of Stroke Prognosis. Neurology. 98:e470-e482. 2022
- Variations in risks from smoking between high-income, middle-income, and low-income countries: an analysis of data from 179 000 participants from 63 countries. The Lancet Global Health. 10:e216-e226. 2022
- Anger or emotional upset and heavy physical exertion as triggers of stroke: the INTERSTROKE study. European Heart Journal. 43:202-209. 2022
- GWAS and ExWAS of blood mitochondrial DNA copy number identifies 71 loci and highlights a potential causal role in dementia. eLife. 11:e70382. 2022
- Household-level lifestyle interventions for the prevention of cognitive decline; A Systematic review. Archives of gerontology and geriatrics. Supplement. 98:104565-104565. 2022
- Hypertension and Cognitive Impairment: A Review of Mechanisms and Key Concepts. Frontiers in Neurology. 13:821135. 2022
- Role of Proxy Respondents in International Stroke Research: Experience of the INTERSTROKE Study. Neuroepidemiology. 56:355-364. 2022
- Feasibility study protocol of a pragmatic, randomised controlled pilot trial: membrane sweeping to prevent post-term pregnancy—the MILO Study. Trials. 22:113. 2021
- Measuring sodium intake: research and clinical applications. Journal of Hypertension. 39:2344-2352. 2021
- Trends in Adaptive Design Methods in Dialysis Clinical Trials: A Systematic Review. Kidney Medicine. 3:925-941. 2021
- Association of Oral Anticoagulation With Stroke in Atrial Fibrillation or Heart Failure. Stroke. 52:3151-3162. 2021
- Sodium Intake and Health: What Should We Recommend Based on the Current Evidence?. Nutrients. 13:3232-3232. 2021
- Stroke Severity in Transcatheter Aortic Valve Implantation Versus Surgical Aortic Valve Replacement: A Systematic Review and Meta-Analysis. Journal of Stroke and Cerebrovascular Diseases. 30:105927-105927. 2021
- Reply. Journal of Hypertension. 39:1467-1469. 2021
- Colchicine for prevention of vascular inflammation in Non-CardioEmbolic stroke (CONVINCE) – study protocol for a randomised controlled trial. European Stroke Journal. 6:222-228. 2021
- Sodium and health: another challenge to the current dogma. European Heart Journal. 42:2116-2118. 2021
- Associations of Fish Consumption With Risk of Cardiovascular Disease and Mortality Among Individuals With or Without Vascular Disease From 58 Countries. JAMA Internal Medicine. 181:631-631. 2021
- Urinary Sodium and Potassium, and Risk of Ischemic and Hemorrhagic Stroke (INTERSTROKE): A Case–Control Study. American Journal of Hypertension. 34:414-425. 2021
- Associations of estimated 24-h urinary sodium excretion with mortality and cardiovascular events in Chinese adults: a prospective cohort study. Journal of Hypertension. 39:484-493. 2021
- Interleukin-6, C-reactive protein, fibrinogen, and risk of recurrence after ischaemic stroke: Systematic review and meta-analysis. European Stroke Journal. 6:62-71. 2021
- Low sodium intake increases plasma renin activity. EClinicalMedicine. 33:100803-100803. 2021
- Efficacy and safety of rivaroxaban plus aspirin in women and men with chronic coronary or peripheral artery disease. Cardioscience. 117:942-949. 2021
- Variations in knowledge, awareness and treatment of hypertension and stroke risk by country income level. Heart. 107:282-289. 2021
- Clarifying Optimal Sodium InTake In Cardiovasular and Kidney (COSTICK) Diseases: a study protocol for two randomised controlled trials. HRB Open Research. 4:14-14. 2021
- Microbleeds and the Effect of Anticoagulation in Patients With Embolic Stroke of Undetermined Source. JAMA Neurology. 78:11-11. 2021
- Renal Impairment and Risk of Acute Stroke: The INTERSTROKE Study. Neuroepidemiology. 55:206-215. 2021
- Cross-sectional study of the association between skin tags and vascular risk factors in a bariatric clinic-based cohort of Irish adults with morbid obesity. BMC Research Notes. 13:156. 2020
- Increased Salt Intake for Orthostatic Intolerance Syndromes: A Systematic Review and Meta-Analysis. American Journal of Medicine. 133:1471-1478.e4. 2020
- Revisiting sequential attributable fractions. Archives of Public Health. 78:67. 2020
- Virtual geriatric clinics and the COVID-19 catalyst: a rapid review. Age and Ageing. 49:907-914. 2020
- Promoting Independent Mobility-related Physical ACTivity (IMPACT) in an inpatient stroke rehabilitation unit: a proof-of-concept evaluation of self-management intervention. Disability and Rehabilitation. 42:3172-3181. 2020
- Population attributable fraction for continuously distributed exposures 2020
- Response to letter: non‐vitamin‐K oral anticoagulants may not significantly reduce the risk of fatal or disabling stroke compared with warfarin. European Journal of Neurology. 27:e56. 2020
- Rivaroxaban for Prevention of Covert Brain Infarcts and Cognitive Decline. Stroke. 51:2901-2909. 2020
- Salt and cardiovascular disease: insufficient evidence to recommend low sodium intake. European Heart Journal. 41:3363-3373. 2020
- Adaptive design methods in dialysis clinical trials: a systematic review protocol. BMJ Open. 10:e036755-e036755. 2020
- Genome-Wide Association Study Meta-Analysis of Stroke in 22 000 Individuals of African Descent Identifies Novel Associations With Stroke. Stroke. 51:2454-2463. 2020
- Association of Blood Pressure Lowering With Incident Dementia or Cognitive Impairment. Journal of the American Medical Association (JAMA). 323:1934-1934. 2020
- Anti-inflammatory therapy for preventing stroke and other vascular events after ischaemic stroke or transient ischaemic attack. Cochrane Database of Systematic Reviews. 2020:CD012825. 2020
- Effect of non‐vitamin‐K oral anticoagulants on stroke severity compared to warfarin: a meta‐analysis of randomized controlled trials. European Journal of Neurology. 27:413-418. 2020
- Modifiable risk factors, cardiovascular disease, and mortality in 155 722 individuals from 21 high-income, middle-income, and low-income countries (PURE): a prospective cohort study. The Lancet. 395:795-808. 2020
- Are large simple trials for dementia prevention possible?. Age and Ageing. 49:154-160. 2020
- Population attributable fractions for continuously distributed exposures. Epidemiologic Methods. 9:20190037. 2020
- <p>Effects of a Milk-Based Meal Replacement Program on Weight and Metabolic Characteristics in Adults with Severe Obesity</p>. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy. Volume 13:197-205. 2020
- Aspirin for primary prevention of stroke in individuals without cardiovascular disease—A meta-analysis. International Journal of Stroke. 15:9-17. 2020
- Graphical comparisons of relative disease burden across multiple risk factors. BMC Medical Research Methodology. 19:186. 2019
- Phenome-wide association analysis of LDL-cholesterol lowering genetic variants in PCSK9. BMC Cardiovascular Disorders. 19:240. 2019
- Risk of bias assessment of sequence generation: a study of 100 systematic reviews of trials. Systematic Reviews. 8:13. 2019
- Bleeding and New Cancer Diagnosis in Patients With Atherosclerosis. Circulation. 140:1451-1459. 2019
- Major Bleeding in Patients With Coronary or Peripheral Artery Disease Treated With Rivaroxaban Plus Aspirin. Journal of the American College of Cardiology. 74:1519-1528. 2019
- Safety of Proton Pump Inhibitors Based on a Large, Multi-Year, Randomized Trial of Patients Receiving Rivaroxaban or Aspirin. Gastroenterology. 157:682-691.e2. 2019
- Letter by Mente et al Regarding Article “Urinary Sodium Excretion, Blood Pressure, and Risk of Future Cardiovascular Disease and Mortality in Subjects Without Prior Cardiovascular Disease”. Hypertension. 74:e26. 2019
- Pantoprazole to Prevent Gastroduodenal Events in Patients Receiving Rivaroxaban and/or Aspirin in a Randomized, Double-Blind, Placebo-Controlled Trial. Gastroenterology. 157:403-412.e5. 2019
- Publisher Correction: Multiancestry genome-wide association study of 520,000 subjects identifies 32 loci associated with stroke and stroke subtypes. Nature Genetics. 51:1192-1193. 2019
- Lipid Lowering Therapy, Low-Density Lipoprotein Level and Risk of Intracerebral Hemorrhage – A Meta-Analysis. Journal of Stroke and Cerebrovascular Diseases. 28:1703-1709. 2019
- Management of dyslipidaemia in patients with coronary heart disease: Results from the ESC-EORP EUROASPIRE V survey in 27 countries. Atherosclerosis. 285:135-146. 2019
- Rationale, design, and baseline participant characteristics in the MRI and cognitive substudy of the cardiovascular outcomes for people using anticoagulation strategies trial. International Journal of Stroke. 14:270-281. 2019
- Effects of blood pressure and lipid lowering on cognition. Neurology. 92:e1435-e1446. 2019
- Joint association of urinary sodium and potassium excretion with cardiovascular events and mortality: prospective cohort study. The BMJ. 364:l772-l772. 2019
- Urinary sodium excretion measures and health outcomes – Authors' reply. The Lancet. 393:1295-1296. 2019
- Serum magnesium and calcium levels in relation to ischemic stroke. Neurology. 92:e944-e950. 2019
- Stroke Outcomes in the COMPASS Trial. Circulation. 139:1134-1145. 2019
- Moyamoya Disease Susceptibility Variant RNF213 p.R4810K Increases the Risk of Ischemic Stroke Attributable to Large-Artery Atherosclerosis. Circulation. 139:295-298. 2019
- Joint incorporation of randomised and observational evidence in estimating treatment effects. Statistical Methods in Medical Research. 28:235-247. 2019
- Global, Regional, and Country-Specific Lifetime Risks of Stroke, 1990 and 2016. New England Journal of Medicine. 379:2429-2437. 2018
- Clopidogrel plus aspirin versus aspirin alone for acute minor ischaemic stroke or high risk transient ischaemic attack: systematic review and meta-analysis. The BMJ. 363:k5108-k5108. 2018
- Dual antiplatelet therapy with aspirin and clopidogrel for acute high risk transient ischaemic attack and minor ischaemic stroke: a clinical practice guideline. The BMJ. 363:k5130-k5130. 2018
- Identifying trial recruitment uncertainties using a James Lind Alliance Priority Setting Partnership – the PRioRiTy (Prioritising Recruitment in Randomised Trials) study. Trials. 19:147. 2018
- Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trial. Lancet Neurology. 17:1053-1060. 2018
- The CHARMS pilot study: a multi-method assessment of the feasibility of a sexual counselling implementation intervention in cardiac rehabilitation in Ireland. Pilot and Feasibility Studies. 4:88. 2018
- Non-vitamin-K oral anticoagulants (NOACs) for the prevention of secondary stroke. Expert Opinion on Pharmacotherapy. 19:1597-1602. 2018
- Urinary sodium excretion, blood pressure, cardiovascular disease, and mortality: a community-level prospective epidemiological cohort study. The Lancet. 392:496-506. 2018
- Patent foramen ovale closure, antiplatelet therapy or anticoagulation therapy alone for management of cryptogenic stroke? A clinical practice guideline. The BMJ. 362:k2515-k2515. 2018
- Rivaroxaban for Stroke Prevention after Embolic Stroke of Undetermined Source. New England Journal of Medicine. 378:2191-2201. 2018
- Characterization of Patients with Embolic Strokes of Undetermined Source in the NAVIGATE ESUS Randomized Trial. Journal of Stroke and Cerebrovascular Diseases. 27:1673-1682. 2018
- Practice patterns and outcomes after stroke across countries at different economic levels (INTERSTROKE): an international observational study. The Lancet. 391:2019-2027. 2018
- Estimating average attributable fractions with confidence intervals for cohort and case–control studies. Statistical Methods in Medical Research. 27:1141-1152. 2018
- Multiancestry genome-wide association study of 520,000 subjects identifies 32 loci associated with stroke and stroke subtypes. Nature Genetics. 50:524-537. 2018
- Response to: ‘More on dissidents and dietary sodium’. International Journal of Epidemiology. 47:673-674. 2018
- Cardiovascular, respiratory, and related disorders: key messages from Disease Control Priorities, 3rd edition. The Lancet. 391:1224-1236. 2018
- Rivaroxaban with or without aspirin in patients with stable coronary artery disease: an international, randomised, double-blind, placebo-controlled trial. The Lancet. 391:205-218. 2018
- Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial. The Lancet. 391:219-229. 2018
- Anti-inflammatory therapy for preventing stroke and other vascular events after ischaemic stroke or transient ischaemic attack. Cochrane Database of Systematic Reviews. 2017. 2017
- COL4A2 is associated with lacunar ischemic stroke and deep ICH. Neurology. 89:1829-1839. 2017
- Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease. New England Journal of Medicine. 377:1319-1330. 2017
- Association of dietary nutrients with blood lipids and blood pressure in 18 countries: a cross-sectional analysis from the PURE study. The Lancet Diabetes and Endocrinology. 5:774-787. 2017
- Availability and affordability of blood pressure-lowering medicines and the effect on blood pressure control in high-income, middle-income, and low-income countries: an analysis of the PURE study data. The Lancet Public Health. 2:e411-e419. 2017
- Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. The Lancet. 390:1260-1344. 2017
- Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. The Lancet. 390:1211-1259. 2017
- Global, regional, and national under-5 mortality, adult mortality, age-specific mortality, and life expectancy, 1970–2016: a systematic analysis for the Global Burden of Disease Study 2016. The Lancet. 390:1084-1150. 2017
- Mendelian Genes and Risk of Intracerebral Hemorrhage and Small-Vessel Ischemic Stroke in Sporadic Cases. Stroke. 48:2263-2265. 2017
- Rationale, Design and Baseline Characteristics of Participants in the C ardiovascular O utco m es for P eople Using A nticoagulation S trategie s (COMPASS) Trial. Canadian Journal of Cardiology. 33:1027-1035. 2017
- A systematic review of interventions to improve outcomes for young adults with Type 1 diabetes. Diabetic Medicine. 34:753-769. 2017
- Response by Smyth et al to Letters Regarding Article, “Physical Activity and Anger or Emotional Upset as Triggers of Acute Myocardial Infarction: The INTERHEART Study”. Circulation. 135:e644-e645. 2017
- The technical report on sodium intake and cardiovascular disease in low- and middle-income countries by the joint working group of the World Heart Federation, the European Society of Hypertension and the European Public Health Association. European Heart Journal. 38:ehw549-ehw549. 2017
- Sleep to Lower Elevated Blood Pressure: A Randomized Controlled Trial (SLEPT). American Journal of Hypertension. 30:319-327. 2017
- Adjusted Analyses in Studies Addressing Therapy and Harm. Journal of the American Medical Association (JAMA). 317:748-748. 2017
- Low sodium intake and cardiovascular health: an unanswered question. Response to: Letter from Dr N. Campbell, ‘Dissidents and dietary sodium. Concerns about the commentary by O’Donnellet al.’. International Journal of Epidemiology. 46:dyw297-dyw297. 2017
- PCSK9 genetic variants and risk of type 2 diabetes: a mendelian randomisation study. The Lancet Diabetes and Endocrinology. 5:97-105. 2017
- The Changing Landscape for Stroke Prevention in AF: Findings From the GLORIA-AF Registry Phase 2. Journal of the American College of Cardiology. 69:777-785. 2017
- The INTERSTROKE study on risk factors for stroke – Authors' reply. The Lancet. 389:36-36. 2017
- Dietary Sodium and Cardiovascular Disease Risk. New England Journal of Medicine. 375:2404-2408. 2016
- Physical Activity and Anger or Emotional Upset as Triggers of Acute Myocardial Infarction. Circulation. 134:1059-1067. 2016
- How Robust Is the Evidence for Recommending Very Low Salt Intake in Entire Populations? ∗. Journal of the American College of Cardiology. 68:1618-1621. 2016
- Sodium and cardiovascular disease – Authors' reply. The Lancet. 388:2113-2114. 2016
- Diet and Major Renal Outcomes: A Prospective Cohort Study. The NIH-AARP Diet and Health Study. Journal of Renal Nutrition. 26:288-298. 2016
- Global Survey of the Frequency of Atrial Fibrillation–Associated Stroke. Stroke. 47:2197-2202. 2016
- Rivaroxaban for secondary stroke prevention in patients with embolic strokes of undetermined source: Design of the NAVIGATE ESUS randomized trial. European Stroke Journal. 1:146-154. 2016
- Covert stroke after non-cardiac surgery: a prospective cohort study. British Journal of Anaesthesia. 117:191-197. 2016
- Effect of apixaban on brain infarction and microbleeds: AVERROES-MRI assessment study. American Heart Journal. 178:145-150. 2016
- Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE): a case-control study. The Lancet. 388:761-775. 2016
- The effect of renal sympathetic denervation on nocturnal dipping in patients with resistant hypertension; observational data from a tertiary referral centre in the Republic of Ireland. Irish Journal of Medical Science. 185:635-641. 2016
- Association of Urinary Sodium Excretion With Blood Pressure and Cardiovascular Clinical Events in 17,033 Latin Americans. American Journal of Hypertension. 29:796-805. 2016
- Associations of urinary sodium excretion with cardiovascular events in individuals with and without hypertension: a pooled analysis of data from four studies. The Lancet. 388:465-475. 2016
- Embolic strokes of undetermined source: Prevalence and patient features in the ESUS Global Registry. International Journal of Stroke. 11:526-533. 2016
- Attitudes to outcomes measured in clinical trials of cardiovascular prevention. QJM - Monthly Journal of the Association of Physicians. 109:391-397. 2016
- Sexual counselling for patients with cardiovascular disease: protocol for a pilot study of the CHARMS sexual counselling intervention. BMJ Open. 6:e011219-e011219. 2016
- Leflunomide Use and Risk of Lung Disease in Rheumatoid Arthritis: A Systematic Literature Review and Metaanalysis of Randomized Controlled Trials. Journal of Rheumatology. 43:855-860. 2016
- Assessing global risk factors for non-fatal injuries from road traffic accidents and falls in adults aged 35–70 years in 17 countries: a cross-sectional analysis of the Prospective Urban Rural Epidemiological (PURE) study. Injury Prevention. 22:92-98. 2016
- Assessment of Dietary Sodium and Potassium in Canadians Using 24-Hour Urinary Collection. Canadian Journal of Cardiology. 32:319-326. 2016
- Peripheral Blood MCEMP1 Gene Expression as a Biomarker for Stroke Prognosis. Stroke. 47:652-658. 2016
- Prevention, management, and rehabilitation of stroke in low- and middle-income countries. eNeurologicalSci. 2:21-30. 2016
- Commentary: Accepting what we don’t know will lead to progress. International Journal of Epidemiology. 45:260-262. 2016
- Correction. Stroke. 47:e20. 2016
- Preconditioning Shields Against Vascular Events in Surgery (SAVES), a multicentre feasibility trial of preconditioning against adverse events in major vascular surgery: study protocol for a randomised control trial. Trials. 16:185. 2015
- A MultiCenter Pilot Randomized Controlled Trial of Remote Ischemic Preconditioning in Major Vascular Surgery. Vascular and Endovascular Surgery. 49:220-227. 2015
- Alcohol consumption and cardiovascular disease, cancer, injury, admission to hospital, and mortality: a prospective cohort study. The Lancet. 386:1945-1954. 2015
- Measuring Sodium Intake in Populations: Simple Is Best?. American Journal of Hypertension. 28:1303-1305. 2015
- Risk of liver injury among methotrexate users: A meta-analysis of randomised controlled trials. Seminars in Arthritis and Rheumatism. 45:156-162. 2015
- Antithrombotic Treatment at Onset of Stroke with Atrial Fibrillation, Functional Outcome, and Fatality: A Systematic Review and Meta-Analysis. International Journal of Stroke. 10:808-814. 2015
- Healthy eating and reduced risk of cognitive decline. Neurology. 84:2258-2265. 2015
- Dietary Sodium and Cardiovascular Disease. Current Hypertension Reports. 17:559. 2015
- Atrial Premature Beats Predict Atrial Fibrillation in Cryptogenic Stroke. Stroke. 46:936-941. 2015
- Response to ‘Estimation of sodium excretion should be made as simple as possible, but not simpler. Journal of Hypertension. 33:887-890. 2015
- When it matters that a ‘Stroke’ is not a stroke. BMJ Case Reports. 2015:bcr2015209636-bcr2015209636. 2015
- Methotrexate use and risk of lung disease in psoriasis, psoriatic arthritis, and inflammatory bowel disease: systematic literature review and meta-analysis of randomised controlled trials. The BMJ. 350:h1269-h1269. 2015
- Sodium Intake and Cardiovascular Health. Circulation Research. 116:1046-1057. 2015
- Impact of Language Barriers on Stroke Care and Outcomes. Stroke. 46:813-818. 2015
- Systolic Blood Pressure Variation and Mean Heart Rate Is Associated With Cognitive Dysfunction in Patients With High Cardiovascular Risk. Hypertension. 65:651-661. 2015
- Does Lowering Blood Pressure With Antihypertensive Therapy Preserve Independence in Activities of Daily Living? A Systematic Review. American Journal of Hypertension. 28:273-279. 2015
- Early cerebral small vessel disease and brain volume, cognition, and gait. Annals of Neurology. 77:251-261. 2015
- The burden of disease in older people and implications for health policy and practice. The Lancet. 385:549-562. 2015
-
d -Dimer Testing to Select Patients With a First Unprovoked Venous Thromboembolism Who Can Stop Anticoagulant Therapy. ACP journal club. 162:27-34. 2015 - Advance preferences regarding thrombolysis in patients at risk for stroke: a cross-sectional study: Table 1. QJM - Monthly Journal of the Association of Physicians. 108:27-31. 2015
- Atlas of the Global Burden of Stroke (1990-2013): The GBD 2013 Study. Neuroepidemiology. 45:230-236. 2015
- Global, regional, and national age–sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. The Lancet. 385:117-171. 2015
- Update on the Global Burden of Ischemic and Hemorrhagic Stroke in 1990-2013: The GBD 2013 Study. Neuroepidemiology. 45:161-176. 2015
- Antithrombotic Therapy After Acute Ischemic Stroke in Patients With Atrial Fibrillation. Stroke. 45:3637-3642. 2014
- Reply to both letters. Journal of Hypertension. 32:2501-2503. 2014
- Sleep to lower elevated blood pressure: study protocol for a randomized controlled trial. Trials. 15:393. 2014
- The relationship between estimated sodium and potassium excretion and subsequent renal outcomes. Kidney International. 86:1205-1212. 2014
- Sodium and Cardiovascular Disease. New England Journal of Medicine. 371:2135-2136. 2014
- Sodium and Cardiovascular Disease. New England Journal of Medicine. 371:2134-2139. 2014
- Sodium and cardiovascular disease.. New England Journal of Medicine. 371:2138-2139. 2014
- Sodium and cardiovascular disease.. New England Journal of Medicine. 371:2136-2137. 2014
- Sodium and cardiovascular disease.. New England Journal of Medicine. 371:2134-2135. 2014
- Sodium and cardiovascular disease.. New England Journal of Medicine. 371:2135-2136. 2014
- Sodium and cardiovascular disease.. New England Journal of Medicine. 371:2137. 2014
- Sodium and cardiovascular disease.. New England Journal of Medicine. 371:2134. 2014
- Reply to: Methotrexate and not much harm to the lungs. Clinical and Experimental Rheumatology. 32:S11-S11. 2014
- Transesophageal echocardiography in patients with cryptogenic ischemic stroke: A systematic review. American Heart Journal. 168:706-712.e14. 2014
- Evidence Relating Sodium Intake to Blood Pressure and CVD. Current Cardiology Reports. 16:529. 2014
- Sodium Intake and Renal Outcomes: A Systematic Review. American Journal of Hypertension. 27:1277-1284. 2014
- Comparing mortality in patients with atrial fibrillation who are receiving a direct‐acting oral anticoagulant or warfarin: a meta‐analysis of randomized trials. Journal of Thrombosis and Haemostasis. 12:1419-1424. 2014
- Reply. Arthritis & Rheumatology. 66:2642-2642. 2014
- Association of Urinary Sodium and Potassium Excretion with Blood Pressure. New England Journal of Medicine. 371:601-611. 2014
- Urinary Sodium and Potassium Excretion, Mortality, and Cardiovascular Events. New England Journal of Medicine. 371:612-623. 2014
- The Mini‐Mental State Examination, Clinical Factors, and Motor Vehicle Crash Risk. Journal of The American Geriatrics Society. 62:1419-1426. 2014
- Aliskiren alone or with other antihypertensives in the elderly with borderline and stage 1 hypertension: the APOLLO trial. European Heart Journal. 35:1743-1751. 2014
- Effectiveness of a smartphone application to promote physical activity in primary care: the SMART MOVE randomised controlled trial. British Journal of General Practice. 64:e384-e391. 2014
- Incidental Magnetic Resonance Diffusion-Weighted Imaging–Positive Lesions Are Rare in Neurologically Asymptomatic Community-Dwelling Adults. Stroke. 45:2115-2117. 2014
- Atrial Fibrillation in Patients with Cryptogenic Stroke. New England Journal of Medicine. 370:2467-2477. 2014
- The Population Risks of Dietary Salt Excess Are Exaggerated. Canadian Journal of Cardiology. 30:507-512. 2014
- The prevalence of vertebral fracture on vertebral fracture assessment imaging in a large cohort of patients with rheumatoid arthritis. Rheumatology. 53:821-827. 2014
- Validation and comparison of three formulae to estimate sodium and potassium excretion from a single morning fasting urine compared to 24-h measures in 11 countries. Journal of Hypertension. 32:1005-1015. 2014
- Embolic strokes of undetermined source: the case for a new clinical construct. Lancet Neurology. 13:429-438. 2014
- Methotrexate and Lung Disease in Rheumatoid Arthritis: A Meta‐Analysis of Randomized Controlled Trials. Arthritis & Rheumatology. 66:803-812. 2014
- Vertebral fracture assessment-detected abdominal aortic calcification and cardiovascular disease in rheumatoid arthritis. Seminars in Arthritis and Rheumatism. 43:632-637. 2014
- Vitamin D supplementation-clarity required regarding treatment regimens and target plasma levels. QJM - Monthly Journal of the Association of Physicians. 107:327-329. 2014
- Myocardial Injury after Noncardiac Surgery. Anesthesiology. 120:564-578. 2014
- Efficacy and Safety of Warfarin VS. Antiplatelet Therapy in Patients with Systolic Heart Failure and Sinus Rhythm: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. International Journal of Stroke. 9:199-206. 2014
- Extended‐duration new oral anticoagulants for venous thromboprophylaxis in patients undergoing total hip arthroplasty: a meta‐analysis of the randomized controlled trials. Journal of Thrombosis and Haemostasis. 12:107-109. 2014
- Global and regional burden of stroke during 1990–2010: findings from the Global Burden of Disease Study 2010. The Lancet. 383:245-255. 2014
- Novel Oral Anticoagulants: A Focused Review for Stroke Physicians. International Journal of Stroke. 9:71-78. 2014
- Reply to: methotrexate and not much harm to the lungs by H. Yazici.. Clinical and Experimental Rheumatology. 32:S-11. 2014
- The Prevalence of Aortic Calcification on Vertebral Fracture Assessment Imaging Among Patients With Rheumatoid Arthritis. Journal of Clinical Densitometry. 17:72-77. 2014
- Vascular Risk Factors, Cardiovascular Disease and Functional Impairment in Community-Dwelling Adults. Gerontology. 60:212-221. 2014
- Global and regional burden of first-ever ischaemic and haemorrhagic stroke during 1990–2010: findings from the Global Burden of Disease Study 2010. The Lancet Global Health. 1:e259-e281. 2013
- Risk factors for stroke in Tanzania. The Lancet Global Health. 1:e241-e242. 2013
- Extreme Sodium Reductions for the Entire Population: Zealotry or Evidence Based?. American Journal of Hypertension. 26:1187-1190. 2013
- Association of atrial fibrillation with mortality and disability after ischemic stroke. Neurology. 81:825-832. 2013
- Assessment of Anticoagulation Intensity and Management of Bleeding With Old and New Oral Anticoagulants. Canadian Journal of Cardiology. 29:S34-S44. 2013
- Mild chronic kidney disease and functional impairment in community-dwelling older adults. Age and Ageing. 42:488-494. 2013
- Mortality Benefits From US Population-Wide Reduction in Sodium Consumption: Projections From 3 Modeling Approaches. Hypertension. 61:e59. 2013
- Chronic Pain Syndromes After Ischemic Stroke. Stroke. 44:1238-1243. 2013
- Salt intake and cardiovascular disease: why are the data inconsistent?. European Heart Journal. 34:1034-1040. 2013
- The PLAN score predicted death and severe disability in patients with acute ischemic stroke. ACP journal club. 158:JC13-JC13. 2013
-
Selective
d -Dimer Testing for Diagnosis of a First Suspected Episode of Deep Venous Thrombosis. ACP journal club. 158:93-93. 2013 - Supporting the improvement and management of prescribing for urinary tract infections (SIMPle): protocol for a cluster randomized trial. Trials. 14:441-441. 2013
- Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. The Lancet. 380:2197-2223. 2012
- Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. The Lancet. 380:2095-2128. 2012
- Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. The Lancet. 380:2163-2196. 2012
- The PLAN Score. JAMA Internal Medicine. 172:1548-1548. 2012
- Genetic risk factors for ischaemic stroke and its subtypes (the METASTROKE Collaboration): a meta-analysis of genome-wide association studies. Lancet Neurology. 11:951-962. 2012
- Estimating treatment effects in observational studies. Neurology. 79:1844-1845. 2012
- Stroke Risk and Efficacy of Apixaban in Atrial Fibrillation Patients with Moderate Chronic Kidney Disease. Journal of Stroke and Cerebrovascular Diseases. 21:429-435. 2012
- Which Risk Factors Are More Associated With Ischemic Stroke Than Intracerebral Hemorrhage in Patients With Atrial Fibrillation?. Stroke. 43:2048-2054. 2012
- Cognitive impairment and risk of cardiovascular events and mortality. European Heart Journal. 33:1777-1786. 2012
- Randomized controlled trials of new oral anticoagulants for stroke prevention in atrial fibrillation. Current Opinion in Cardiology. 27:331-339. 2012
- Error in Viewpoint in: Statin Therapy for Healthy Men Identified as ‘Increased Risk,’. Journal of the American Medical Association (JAMA). 307:2590-2590. 2012
- Association Between Postoperative Troponin Levels and 30-Day Mortality Among Patients Undergoing Noncardiac Surgery. Journal of the American Medical Association (JAMA). 307:2295-2295. 2012
- Increased risk of cognitive and functional decline in patients with atrial fibrillation: results of the ONTARGET and TRANSCEND studies. CANADIAN MEDICAL ASSOCIATION JOURNAL. 184:E329-E336. 2012
- Preventing cardiovascular disease in primary care: Role of a national risk factor management program. American Heart Journal. 163:714-719. 2012
- Urinary Sodium Excretion and Cardiovascular Events—Reply. Journal of the American Medical Association (JAMA). 307:1139-1139. 2012
- Apixaban versus aspirin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a predefined subgroup analysis from AVERROES, a randomised trial. Lancet Neurology. 11:225-231. 2012
- Randomized controlled trial of a new portable calf compression device (Venowave) for prevention of venous thrombosis in high‐risk neurosurgical patients. Journal of Thrombosis and Haemostasis. 10:229-235. 2012
- Antithrombotic and thrombolytic therapy for ischemic stroke: antithrombotic therapy and prevention of thrombosis: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 141:e601S-e636S. 2012
- Methodology of the Global and Regional Burden of Stroke Study. Neuroepidemiology. 38:30-40. 2012
- The iScore Predicts Poor Functional Outcomes Early After Hospitalization for an Acute Ischemic Stroke. Stroke. 42:3421-3428. 2011
- Urinary Sodium and Potassium Excretion and Risk of Cardiovascular Events. Journal of the American Medical Association (JAMA). 306:2229-2238. 2011
- Care and outcomes in patients with ischemic stroke with and without preexisting dementia. Neurology. 77:1664-1673. 2011
- Effect of Aspirin on Mortality in the Primary Prevention of Cardiovascular Disease. American Journal of Medicine. 124:621-629. 2011
- Fine Particulate Air Pollution (PM2.5) and the Risk of Acute Ischemic Stroke. Epidemiology. 22:422-431. 2011
- Should Patients With Stroke Wear Compression Stockings?. ACP journal club. 154:506-506. 2011
- Apixaban in Patients with Atrial Fibrillation. New England Journal of Medicine. 364:806-817. 2011
- IScore. Circulation. 123:739-749. 2011
- Albuminuria and Decline in Cognitive Function<subtitle>The ONTARGET/TRANSCEND Studies</subtitle><alt-title>Albuminuria and Decline in Cognitive Function</alt-title>. JAMA Internal Medicine. 171:142-142. 2011
- Association between time-to-presentation and clinical outcome in patients with subarachnoid hemorrhage: an observational study.. Canadian journal of neuroscience nursing. 33:33-37. 2011
- Graduated compression stockings to prevent venous thromboembolism in hospital. Evidence from patients with acute stroke. Polskie Archiwum Medycyny Wewnetrznej. 121:40-43. 2011
- In response. Annals of Internal Medicine. 154:506. 2011
- Validity of Composite Outcomes in Meta-Analyses of Stroke Prevention Trials: The Case of Aspirin. Cerebrovascular Diseases. 32:22-27. 2011
- Efficacy and safety of fondaparinux in patients with ST-segment elevation myocardial infarction across the age spectrum. Results from the Organization for the Assessment of Strategies for Ischemic Syndromes 6 (OASIS-6) trial. American Heart Journal. 160:1049-1055. 2010
- Should Patients With Stroke Wear Compression Stockings to Prevent Venous Thromboembolism?. ACP journal club. 153:610-610. 2010
- How generalisable is INTERSTROKE? – Authors' reply. The Lancet. 376:1539-1539. 2010
- Possible Influence of Stroke Etiology on Hemorrhagic Transformation Following Thrombolysis in Warfarin-Treated Patients. JAMA Neurology. 67:1413-1413. 2010
- Intracranial and fatal bleeding according to indication for long‐term oral anticoagulant therapy. Journal of Thrombosis and Haemostasis. 8:2201-2207. 2010
- Reliability of Proxy Respondents for Patients With Stroke: A Systematic Review. Journal of Stroke and Cerebrovascular Diseases. 19:410-416. 2010
- Do all ischemic stroke subtypes benefit from organized inpatient stroke care?. Neurology. 75:456-462. 2010
- Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study. The Lancet. 376:112-123. 2010
- Rationale and design of AVERROES: Apixaban versus acetylsalicylic acid to prevent stroke in atrial fibrillation patients who have failed or are unsuitable for vitamin K antagonist treatment. American Heart Journal. 159:348-353.e1. 2010
- Rationale and Design of INTERSTROKE: A Global Case-Control Study of Risk Factors for Stroke. Neuroepidemiology. 35:36-44. 2010
- Major Bleeding, Mortality, and Efficacy of Fondaparinux in Venous Thromboembolism Prevention Trials. Circulation. 120:2006-2011. 2009
- New Anticoagulants for Atrial Fibrillation. Seminars in Vascular Medicine. 35:711-711. 2009
- In‐hospital myocardial infarction following acute ischaemic stroke: an observational study. European Journal of Neurology. 16:1035-1040. 2009
- GASTROINTESTINAL BLEEDING AFTER ACUTE ISCHEMIC STROKE. Neurology. 73:160-161. 2009
- New Anticoagulants for Atrial Fibrillation. Seminars in Vascular Medicine. 35:515-524. 2009
- Event adjudication and data monitoring in an intensive care unit observational study of thromboprophylaxis. Journal of Critical Care. 24:168-175. 2009
- Prevalence of cardiovascular risk factors in the Middle East: a systematic review. European Journal of Preventive Cardiology (EJPC). 16:268-280. 2009
- Tackling the global burden of stroke: the need for large-scale international studies. Lancet Neurology. 8:306-307. 2009
- Risk Factors for Posterior Compared to Anterior Ischemic Stroke: An Observational Study of the Registry of the Canadian Stroke Network. Neuroepidemiology. 33:12-16. 2009
- Prophylaxis Against Deep Vein Thrombosis in Critically Ill Patients With Severe Renal Insufficiency With the Low-Molecular-Weight Heparin Dalteparin<subtitle>An Assessment of Safety and Pharmacodynamics: The DIRECT Study</subtitle>. JAMA Internal Medicine. 168:1805-1805. 2008
- Correction. Stroke. 39:E147-E147. 2008
- Escalating Levels of Access to In-Hospital Care and Stroke Mortality. Stroke. 39:2522-2530. 2008
- Using aspirin to prevent cognitive decline. The BMJ. 337:a958-a958. 2008
- Gastrointestinal bleeding after acute ischemic stroke. Neurology. 71:650-655. 2008
- Variables Associated With 7-Day, 30-Day, and 1-Year Fatality After Ischemic Stroke. Stroke. 39:2318-2324. 2008
- Response to Letter by Haft. Stroke. 39:E92-E92. 2008
- Antiplatelet Therapy for Secondary Prevention of Noncardioembolic Ischemic Stroke. Stroke. 39:1638-1646. 2008
- Perioperative Management of Oral Anticoagulation. Cardiology Clinics. 26:299-309. 2008
- Response to Letter Regarding Article, “Challenges of Establishing New Antithrombotic Therapies in Atrial Fibrillation”. Circulation. 117:E150-E150. 2008
- Clinical factors influencing normalization of prothrombin time after stopping warfarin: a retrospective cohort study. Thrombosis Journal. 6:15-15. 2008
- Evaluation of a venous-return assist device to treat severe post-thrombotic syndrome (VENOPTS). Thrombosis and Haemostasis. 99:623-629. 2008
- Venous thromboembolism and bleeding in critically ill patients with severe renal insufficiency receiving dalteparin prophylaxis: prevalence, incidence and risk factors. Critical Care. 12:R32-R32. 2008
- Bridging Low-Molecular-Weight Heparin for Temporary Interruption of Warfarin. ACP journal club. 147:671-671. 2007
- In response. Annals of Internal Medicine. 147:671. 2007
- Noninvasive Cardiac Monitoring for Detecting Paroxysmal Atrial Fibrillation or Flutter After Acute Ischemic Stroke. Stroke. 38:2935-2940. 2007
- Hospital volume and stroke outcome. Neurology. 69:1142-1151. 2007
- Beyond Unfractionated Heparin and Warfarin. Circulation. 116:552-560. 2007
- Challenges of Establishing New Antithrombotic Therapies in Atrial Fibrillation. Circulation. 116:449-455. 2007
- In reply [10]. Journal of the American Medical Association (JAMA). 297:1881-1882. 2007
- Pexelizumab and the APEX AMI Trial—Reply. Journal of the American Medical Association (JAMA). 297:1877-1877. 2007
- Behavioural and Psychological Symptoms in Community-Dwelling Elderly Persons with Cognitive Impairment and Dementia. Clinical Gerontologist. 30:41-52. 2007
- Thromboembolism prevention in ischaemic stroke. The Lancet. 369:1413-1415. 2007
- Brief Communication: Preoperative Anticoagulant Activity after Bridging Low-Molecular-Weight Heparin for Temporary Interruption of Warfarin. ACP journal club. 146:184-184. 2007
- Pexelizumab Does Not “Complement” Percutaneous Coronary Intervention in Patients With ST-Elevation Myocardial Infarction. Journal of the American Medical Association (JAMA). 297:91-91. 2007
- Pre-admission warfarin use in patients with acute ischemic stroke and atrial fibrillation: The appropriate use and barriers to oral anticoagulant therapy. Thrombosis Research. 120:663-669. 2007
- Thyroid replacement therapy and atrial fibrillation in acute ischemic stroke. Neurology. 67:1714-1715. 2006
- Functional analysis of Sox8 during neural crest development in Xenopus. Development. 133:3950-3950. 2006
- Preadmission antithrombotic treatment and stroke severity in patients with atrial fibrillation and acute ischaemic stroke: an observational study. Lancet Neurology. 5:749-754. 2006
- ESPRIT trial. The Lancet. 368:447-447. 2006
- Clinical trials of new anticoagulants.. Vnitrni Lekarstvi. 52 Suppl 1:123-126. 2006
- Are There Patients With Acute Ischemic Stroke and Atrial Fibrillation That Benefit From Low Molecular Weight Heparin?. Stroke. 37:452-455. 2006
- Perioperative Management of Oral Anticoagulation. Clinics in Geriatric Medicine. 22:199-213. 2006
- Emerging therapies for stroke prevention in atrial fibrillation. European Heart Journal, Supplement. 7:C19-C27. 2005
- Risk of bleeding with vitamin K antagonists compared with low-molecular-weight heparin after orthopedic surgery: a rebuttal. Journal of Thrombosis and Haemostasis. 3:606-608. 2005
- New anticoagulants. Blood. 105:453-463. 2005
- The Self-Perceived Role and Educational Needs of Pharmaceutical Representatives: A Survey. Education for Health. 17:339-345. 2004
- Methodology for Guideline Development for the Seventh American College of Chest Physicians Conference on Antithrombotic and Thrombolytic Therapy. Chest. 126:174S-178S. 2004
- Novel antithrombotic therapies for the prevention of stroke in patients with atrial fibrillation.. American Journal of Managed Care. 10:S72-S82. 2004
- Establishing an Optimal Therapeutic Range for Coumarins. JAMA Internal Medicine. 164:588-588. 2004
- A Randomized, Controlled Trial of Doxycycline and Rifampin for Patients with Alzheimer's Disease. Journal of The American Geriatrics Society. 52:381-387. 2004
- Low-Molecular-Weight Heparin in Acute Coronary Syndromes. Cardiology. 4:111-118. 2004
- Reduction of Out-of-Hospital Symptomatic Venous Thromboembolism by Extended Thromboprophylaxis With Low-Molecular-Weight Heparin Following Elective Hip Arthroplasty. JAMA Internal Medicine. 163:1362-1362. 2003
- Validity of Self-Reports in Dementia Research. Clinical Gerontologist. 26:155-163. 2003
-
A Diagnostic Strategy Involving a Quantitative Latex
d -Dimer Assay Reliably Excludes Deep Venous Thrombosis. ACP journal club. 138:787-787. 2003 - Thromboprophylaxis in surgical patients.. Canadian Journal of Surgery. 46:129-135. 2003
- New Glaucoma Medications in the Geriatric Population: Efficacy and Safety. Journal of The American Geriatrics Society. 50:956-962. 2002
- Subclinical anaemia of chronic disease in adult patients with cystic fibrosis. Journal of Cystic Fibrosis. 1:31-34. 2002
- The Zarit Burden Interview. The Gerontologist. 41:652-657. 2001
- Venous thromboembolism after long flights: are airlines to blame?. The Lancet. 357:1461-1462. 2001
-
preprints